235 related articles for article (PubMed ID: 7539525)
1. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein.
Megerian G; Godmilow L; Donnenfeld AE
Obstet Gynecol; 1995 Jun; 85(6):952-6. PubMed ID: 7539525
[TBL] [Abstract][Full Text] [Related]
2. The association of aneuploidy and unexplained elevated maternal serum alpha-fetoprotein.
Hiett AK; Callaghan CM; Brown HL; Golichowski AM; Heerema NA
J Perinatol; 1998; 18(5):343-6. PubMed ID: 9766408
[TBL] [Abstract][Full Text] [Related]
3. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
Warner AA; Pettenati MJ; Burton BK
Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
[TBL] [Abstract][Full Text] [Related]
4. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
[TBL] [Abstract][Full Text] [Related]
5. Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities.
Stiller RJ; de Regt RH; Suntag S; Baumgarten A; Hobbins JC; Mahoney MJ
Obstet Gynecol; 1990 Jun; 75(6):994-7. PubMed ID: 1692983
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
Kaffe S; Hsu LY
Am J Med Genet; 1992 Apr; 42(6):801-6. PubMed ID: 1372793
[TBL] [Abstract][Full Text] [Related]
7. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
[TBL] [Abstract][Full Text] [Related]
8. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis of the distal 11q deletion and review of the literature.
Chen CP; Chern SR; Chang TY; Tzen CY; Lee CC; Chen WL; Chen LF; Wang W
Prenat Diagn; 2004 Feb; 24(2):130-6. PubMed ID: 14974122
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
[TBL] [Abstract][Full Text] [Related]
11. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
[TBL] [Abstract][Full Text] [Related]
12. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
Schell DL; Drugan A; Brindley BA; Zador IE; Johnson MP; Schwartz DB; Evans MI
J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
[TBL] [Abstract][Full Text] [Related]
13. Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
Drugan A; Dvorin E; Koppitch FC; Greb A; Krivchenia EL; Evans MI
Obstet Gynecol; 1989 Feb; 73(2):271-4. PubMed ID: 2463504
[TBL] [Abstract][Full Text] [Related]
14. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
[TBL] [Abstract][Full Text] [Related]
15. Fetal karyotyping for chromosome abnormalities after an unexplained elevated maternal serum alpha-fetoprotein screening.
Feuchtbaum LB; Cunningham G; Waller DK; Lustig LS; Tompkinson DG; Hook EB
Obstet Gynecol; 1995 Aug; 86(2):248-54. PubMed ID: 7542378
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound detection of fetal aneuploidy in patients with elevated maternal serum alpha-fetoprotein.
Barth WH; Frigoletto FD; Krauss CM; MacMillin MD; Stryker JM; Benacerraf BR
Obstet Gynecol; 1991 Jun; 77(6):897-900. PubMed ID: 1709481
[TBL] [Abstract][Full Text] [Related]
17. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
18. [Incidence of fetal chromosomal aberration in prenatal cytogenetic examination].
Uehara S; Takabayashi T; Miyashita N; Kosuge S; Murotsuki J; Kurahayashi Y; Kimura H; Iwamoto M; Endo H; Watanabe T
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1333-40. PubMed ID: 1955786
[TBL] [Abstract][Full Text] [Related]
19. Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older: collaborative study of 5484 cases.
Yaegashi N; Senoo M; Uehara S; Suzuki H; Maeda T; Fujimori K; Hirahara F; Yajima A
J Hum Genet; 1998; 43(2):85-90. PubMed ID: 9621511
[TBL] [Abstract][Full Text] [Related]
20. Amniotic fluid alpha fetoprotein (AFAFP) and maternal serum alpha fetoprotein (MSAFP) in abdominal pregnancies: correlation with extent and site of placental implantation and clinical implications.
Shumway JB; Greenspoon JS; Khouzami AN; Platt LD; Blakemore KJ
J Matern Fetal Med; 1996; 5(3):120-3. PubMed ID: 8796780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
